William Blair & Company’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
10,852
-8,171
-43% -$1.76M 0.01% 693
2025
Q4
$3.91M Sell
19,023
-2,144
-10% -$403K 0.01% 583
2025
Q3
$3.32M Buy
21,167
+199
+0.9% +$30.7K 0.01% 613
2025
Q2
$3.52M Buy
20,968
+9,333
+80% +$1.39M 0.01% 587
2025
Q1
$1.6M Sell
11,635
-1,119
-9% -$143K ﹤0.01% 767
2024
Q4
$1.51M Buy
12,754
+1,618
+15% +$189K ﹤0.01% 778
2024
Q3
$1.23M Sell
11,136
-306
-3% -$32K ﹤0.01% 846
2024
Q2
$1.12M Buy
11,442
+103
+0.9% +$10.5K ﹤0.01% 837
2024
Q1
$1.27M Sell
11,339
-44
-0.4% -$4.75K ﹤0.01% 799
2023
Q4
$1.15M Buy
11,383
+366
+3% +$36.3K ﹤0.01% 815
2023
Q3
$957K Sell
11,017
-919
-8% -$83.1K ﹤0.01% 854
2023
Q2
$1.13M Sell
11,936
-364
-3% -$30.7K ﹤0.01% 810
2023
Q1
$929K Buy
12,300
+870
+8% +$65.6K ﹤0.01% 850
2022
Q4
$879K Sell
11,430
-112
-1% -$8.51K ﹤0.01% 866
2022
Q3
$770K Sell
11,542
-271
-2% -$17.2K ﹤0.01% 903
2022
Q2
$617K Buy
11,813
+44
+0.4% +$2.5K ﹤0.01% 997
2022
Q1
$667K Buy
11,769
+734
+7% +$39.3K ﹤0.01% 1056
2021
Q4
$568K Buy
11,035
+664
+6% +$32.6K ﹤0.01% 1167
2021
Q3
$513K Sell
10,371
-1,846
-15% -$100K ﹤0.01% 1148
2021
Q2
$697K Sell
12,217
-1,123
-8% -$65.6K ﹤0.01% 1041
2021
Q1
$810K Buy
13,340
+921
+7% +$50.8K ﹤0.01% 965
2020
Q4
$665K Buy
12,419
+525
+4% +$27.2K ﹤0.01% 996
2020
Q3
$558K Sell
11,894
-207
-2% -$10.6K ﹤0.01% 939
2020
Q2
$632K Sell
12,101
-10,144
-46% -$523K ﹤0.01% 877
2020
Q1
$1.07M Sell
22,245
-2,656
-11% -$138K 0.01% 646
2019
Q4
$1.26M Buy
24,901
+631
+3% +$32.6K 0.01% 720
2019
Q3
$1.15M Buy
24,270
+1,824
+8% +$83.3K 0.01% 708
2019
Q2
$1.06M Sell
22,446
-1,894
-8% -$87.4K 0.01% 742
2019
Q1
$1.17M Buy
24,340
+1,147
+5% +$57.5K 0.01% 694
2018
Q4
$1.03M Sell
23,193
-71
-0.3% -$3.7K 0.01% 684
2018
Q3
$1.26M Sell
23,264
-2,702
-10% -$138K 0.01% 671
2018
Q2
$1.27M Sell
25,966
-6,362
-20% -$361K 0.01% 650
2018
Q1
$2.03M Sell
32,328
-24
-0.1% -$1.65K 0.01% 550
2017
Q4
$1.98M Sell
32,352
-10,644
-25% -$658K 0.01% 575
2017
Q3
$2.88M Sell
42,996
-1,531
-3% -$108K 0.02% 465
2017
Q2
$3.47M Sell
44,527
-93
-0.2% -$7.02K 0.03% 427
2017
Q1
$3.64M Sell
44,620
-5,889
-12% -$464K 0.03% 390
2016
Q4
$3.63M Sell
50,509
-660
-1% -$47.7K 0.03% 366
2016
Q3
$3.98M Sell
51,169
-219
-0.4% -$17.7K 0.04% 347
2016
Q2
$4.01M Buy
51,388
+3,717
+8% +$296K 0.04% 323
2016
Q1
$3.91M Sell
47,671
-4,633
-9% -$377K 0.04% 319
2015
Q4
$4.67M Sell
52,304
-6,564
-11% -$557K 0.04% 306
2015
Q3
$4.52M Buy
58,868
+15,134
+35% +$1.26M 0.04% 330
2015
Q2
$3.66M Sell
43,734
-1,080
-2% -$95.4K 0.01% 1154
2015
Q1
$4.04M Sell
44,814
-650
-1% -$56K 0.01% 1097
2014
Q4
$3.67M Buy
45,464
+490
+1% +$38.7K 0.01% 1123
2014
Q3
$3.37M Buy
44,974
+13,885
+45% +$1.01M 0.01% 1112
2014
Q2
$2.13M Buy
31,089
+3,073
+11% +$209K ﹤0.01% 1222
2014
Q1
$1.96M Buy
28,016
+1,518
+6% +$106K ﹤0.01% 1208
2013
Q4
$1.77M Sell
26,498
-5,950
-18% -$364K ﹤0.01% 1207
2013
Q3
$1.69M Sell
32,448
-10,157
-24% -$516K ﹤0.01% 1181
2013
Q2
$2.01M Buy
+42,605
New +$1.95M ﹤0.01% 1079

Other funds holding CAH

William Blair & Company's CAH Position: Q1 2026 in Review

William Blair & Company reduced its Cardinal Health (CAH) stake by 43% in Q1 2026, selling an estimated $1.76M and leaving 10,852 shares worth $2.29M. The position accounts for 0.01% of the portfolio, ranked #693.

William Blair & Company first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.67M in Q4 2015. 1,429 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • William Blair & Company held 10,852 shares of Cardinal Health worth $2.29M as of Q1 2026.
  • William Blair & Company sold 8,171 Cardinal Health shares in Q1 2026, an estimated $1.76M.
  • Cardinal Health made up 0.01% of William Blair & Company's portfolio in Q1 2026, its #693 holding.
  • William Blair & Company first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Cardinal Health position peaked at $4.67M in Q4 2015.
  • 1,429 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.